Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16570050rdf:typepubmed:Citationlld:pubmed
pubmed-article:16570050lifeskim:mentionsumls-concept:C0006118lld:lifeskim
pubmed-article:16570050lifeskim:mentionsumls-concept:C1327616lld:lifeskim
pubmed-article:16570050lifeskim:mentionsumls-concept:C0030946lld:lifeskim
pubmed-article:16570050lifeskim:mentionsumls-concept:C0596087lld:lifeskim
pubmed-article:16570050lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:16570050lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:16570050lifeskim:mentionsumls-concept:C0871161lld:lifeskim
pubmed-article:16570050lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:16570050pubmed:issue8lld:pubmed
pubmed-article:16570050pubmed:dateCreated2006-4-19lld:pubmed
pubmed-article:16570050pubmed:abstractTextAngiogenesis and extracellular matrix degradation are key events in tumour progression, and factors regulating stromal-epithelial interactions and matrix composition are potential targets for the development of novel anti-invasive/antiangiogenic therapies. Here, we examine the expression of ADAMTS-8, a secreted protease with antiangiogenic properties, in brain tissues. Using quantitative RT-polymerase chain reaction (PCR), high, equivalent expression of ADAMTS-8 was found in normal whole brain, cerebral cortex, frontal lobe, cerebellum and meninges. ADAMTS-8 expression in 34 brain tumours (including 22 high-grade gliomas) and four glioma cell lines indicated at least two-fold reduction in mRNA compared to normal whole brain in all neoplastic tissues, and no detectable expression in 14 out of 34 (41%) tumours or four out of four (100%) cell lines. In contrast, differential expression of TSP1 and VEGF was seen in nine out of 15 (60%) and seven out of 13 (54%) tumours, with no relationship in the expression of these genes. Immunohistochemistry and Western analysis indicated downregulation of ADAMTS-8 protein in >77% tumours. Methylation-specific PCR analysis of ADAMTS-8 indicated promoter hypermethylation in one out of 24 brain tumours (a metastasis) and three out of four glioma cell lines suggesting an alternative mechanism of downregulation. These data suggest a role for ADAMTS-8 in brain tumorigenesis, warranting further investigation into its role in regulation of tumour angiogenesis and local invasion.lld:pubmed
pubmed-article:16570050pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16570050pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16570050pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16570050pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16570050pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16570050pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16570050pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16570050pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16570050pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16570050pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16570050pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16570050pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16570050pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16570050pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16570050pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16570050pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16570050pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16570050pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16570050pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16570050pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16570050pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16570050pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16570050pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16570050pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16570050pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16570050pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16570050pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16570050pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16570050pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16570050pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16570050pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16570050pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16570050pubmed:languageenglld:pubmed
pubmed-article:16570050pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16570050pubmed:citationSubsetIMlld:pubmed
pubmed-article:16570050pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16570050pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16570050pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16570050pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16570050pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16570050pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16570050pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16570050pubmed:statusMEDLINElld:pubmed
pubmed-article:16570050pubmed:monthAprlld:pubmed
pubmed-article:16570050pubmed:issn0007-0920lld:pubmed
pubmed-article:16570050pubmed:authorpubmed-author:ReevesPPlld:pubmed
pubmed-article:16570050pubmed:authorpubmed-author:ShawE JEJlld:pubmed
pubmed-article:16570050pubmed:authorpubmed-author:ReedJ EJElld:pubmed
pubmed-article:16570050pubmed:authorpubmed-author:WalkerCClld:pubmed
pubmed-article:16570050pubmed:authorpubmed-author:DunnJ RJRlld:pubmed
pubmed-article:16570050pubmed:authorpubmed-author:WarnkePPlld:pubmed
pubmed-article:16570050pubmed:authorpubmed-author:GeeA LALlld:pubmed
pubmed-article:16570050pubmed:authorpubmed-author:du PlessisD...lld:pubmed
pubmed-article:16570050pubmed:issnTypePrintlld:pubmed
pubmed-article:16570050pubmed:day24lld:pubmed
pubmed-article:16570050pubmed:volume94lld:pubmed
pubmed-article:16570050pubmed:ownerNLMlld:pubmed
pubmed-article:16570050pubmed:authorsCompleteYlld:pubmed
pubmed-article:16570050pubmed:pagination1186-93lld:pubmed
pubmed-article:16570050pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:16570050pubmed:meshHeadingpubmed-meshheading:16570050...lld:pubmed
pubmed-article:16570050pubmed:meshHeadingpubmed-meshheading:16570050...lld:pubmed
pubmed-article:16570050pubmed:meshHeadingpubmed-meshheading:16570050...lld:pubmed
pubmed-article:16570050pubmed:meshHeadingpubmed-meshheading:16570050...lld:pubmed
pubmed-article:16570050pubmed:meshHeadingpubmed-meshheading:16570050...lld:pubmed
pubmed-article:16570050pubmed:meshHeadingpubmed-meshheading:16570050...lld:pubmed
pubmed-article:16570050pubmed:meshHeadingpubmed-meshheading:16570050...lld:pubmed
pubmed-article:16570050pubmed:meshHeadingpubmed-meshheading:16570050...lld:pubmed
pubmed-article:16570050pubmed:meshHeadingpubmed-meshheading:16570050...lld:pubmed
pubmed-article:16570050pubmed:meshHeadingpubmed-meshheading:16570050...lld:pubmed
pubmed-article:16570050pubmed:meshHeadingpubmed-meshheading:16570050...lld:pubmed
pubmed-article:16570050pubmed:meshHeadingpubmed-meshheading:16570050...lld:pubmed
pubmed-article:16570050pubmed:meshHeadingpubmed-meshheading:16570050...lld:pubmed
pubmed-article:16570050pubmed:meshHeadingpubmed-meshheading:16570050...lld:pubmed
pubmed-article:16570050pubmed:meshHeadingpubmed-meshheading:16570050...lld:pubmed
pubmed-article:16570050pubmed:meshHeadingpubmed-meshheading:16570050...lld:pubmed
pubmed-article:16570050pubmed:year2006lld:pubmed
pubmed-article:16570050pubmed:articleTitleExpression of ADAMTS-8, a secreted protease with antiangiogenic properties, is downregulated in brain tumours.lld:pubmed
pubmed-article:16570050pubmed:affiliationJK Douglas Cancer Research Laboratories, Clatterbridge Hospital, Bebington, Wirral CH64 3JY, and Department of Neurological Science, University of Liverpool, UK. julie.dunn@ccrt.nhs.uklld:pubmed
pubmed-article:16570050pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16570050pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:16570050pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:11095entrezgene:pubmedpubmed-article:16570050lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:16570050lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16570050lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16570050lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16570050lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16570050lld:pubmed